Agree(ADC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ADC Agree

Not Yet Opened 06-02 16:00:00 EDT

72.68

+0.21

+0.29%

盘后72.68

+0.000.00%

19:45 EDT

High73.01	Low72.26	Vol1.25M
Open72.73	D1 Closing72.47	Amplitude1.03%
Mkt Cap8.72B	Tradable Cap7.88B	Total Shares120.03M
T/O90.81M	T/O Rate1.15%	Tradable Shares108.37M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ADC","market":"US","secType":"STK","nameCN":"Agree","latestPrice":72.68,"timestamp":1780430400000,"preClose":72.47,"halted":0,"volume":1250062,"hourTrading":{"tag":"盘后","latestPrice":72.68,"preClose":72.68,"latestTime":"19:45 EDT","volume":275405,"amount":20016435.17,"timestamp":1780443931649,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.0028977507934318746,"floatShares":108366822,"shares":120028300,"eps":1.85165,"marketStatus":"Not Yet Opened","change":0.21,"latestTime":"06-02 16:00:00 EDT","open":72.73,"high":73.01,"low":72.26,"amount":90812571.58014801,"amplitude":0.010349,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.85165,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1780473600000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":766296000000,"exchange":"NYSE","adjPreClose":72.47,"dividendRate":0.042757,"preHourTrading":{"tag":"盘前","latestPrice":73.2155,"preClose":72.47,"latestTime":"08:32 EDT","volume":18,"amount":1316.0305799999999,"timestamp":1780403540821,"change":0.7455,"changeRate":0.010287,"amplitude":0.010287},"postHourTrading":{"tag":"盘后","latestPrice":72.68,"preClose":72.68,"latestTime":"19:45 EDT","volume":275405,"amount":20016435.17,"timestamp":1780443931649,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.96696,"impliedVol":0.1776,"impliedVolPercentile":0.1116},"requestUrl":"/m/hq/s/ADC/wiki","defaultTab":"wiki","newsList":[{"id":"2640690929","title":"ADC Therapeutics Shareholders Back Governance and Capital Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2640690929","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640690929?lang=en_us&edition=fundamental","pubTime":"2026-06-03 05:50","pubTimestamp":1780437005,"startTime":"0","endTime":"0","summary":"The latest announcement is out from ADC Therapeutics ( ($ADCT) ). ADC Therapeutics SA held its 2026 annual general meeting of shareholders on June ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/adc-therapeutics-shareholders-back-governance-and-capital-changes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/adc-therapeutics-shareholders-back-governance-and-capital-changes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4080","BK4231","BK4007","LENZ","BK4139","ADC","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640175949","title":"BeyondSpring Presents the Latest Update of a Phase 2 Study Demonstrating Durable Clinical Benefit of Pembrolizumab Plus Plinabulin/Docetaxel in Metastatic NSCLC After Progression on First-Line Immune Checkpoint Inhibitor Therapy at ASCO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2640175949","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640175949?lang=en_us&edition=fundamental","pubTime":"2026-06-02 19:00","pubTimestamp":1780398000,"startTime":"0","endTime":"0","summary":"Meaningful clinical benefit: Median PFS at 7.0 months, median DoR is 9.3 months with DCR of 79.5% in metastatic NSCLC patients with acquired resistance to immune checkpoint inhibitorsDurable survival ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/02/3304984/0/en/BeyondSpring-Presents-the-Latest-Update-of-a-Phase-2-Study-Demonstrating-Durable-Clinical-Benefit-of-Pembrolizumab-Plus-Plinabulin-Docetaxel-in-Metastatic-NSCLC-After-Progression-o.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4080","ADC","L","BK4585","PFS","LU2487616109.SGD","BK4588","BK4107","BK4139","AR","BK4195","LU0210528500.USD","ORR","BYSI","LU0053666078.USD","BK4231","BK4211","BK4213"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640967966","title":"Trump Says Israel, Hezbollah Agree to No Attacks","url":"https://stock-news.laohu8.com/highlight/detail?id=2640967966","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640967966?lang=en_us&edition=fundamental","pubTime":"2026-06-02 01:41","pubTimestamp":1780335706,"startTime":"0","endTime":"0","summary":"Trump Says Israel, Hezbollah Agree to No Attacks","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4080","BK4231","ADC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640546619","title":"Agree Realty Coverage Assumed by Jefferies at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2640546619","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640546619?lang=en_us&edition=fundamental","pubTime":"2026-06-01 20:56","pubTimestamp":1780318560,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ADC/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 01, 2026 08:56 ET (12:56 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4231","ADC","BK4080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640951862","title":"NextCure Presents Positive SIM0505 Phase 1 Dose Escalation Data in Patients with Gynecologic Cancers at ASCO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2640951862","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640951862?lang=en_us&edition=fundamental","pubTime":"2026-06-01 20:00","pubTimestamp":1780315200,"startTime":"0","endTime":"0","summary":"55% ORR in gynecologic cancers with 52.9% in ovarian and 66.7% in USC at 12 weeks by best response per RECIST 1.1 within the therapeutic dose range (4.8 – 8.0 mg/kg)Favorable safety and tolerability i","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/01/3304283/0/en/NextCure-Presents-Positive-SIM0505-Phase-1-Dose-Escalation-Data-in-Patients-with-Gynecologic-Cancers-at-ASCO-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4213","RCC","BK4007","ADC","BK4231","KOL","ORR","PROC","BK4080","PR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640959383","title":"BriaCell Presents Positive Clinical Data at ASCO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2640959383","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640959383?lang=en_us&edition=fundamental","pubTime":"2026-06-01 19:30","pubTimestamp":1780313400,"startTime":"0","endTime":"0","summary":"Final Bria-IMT Phase 2 data show 55% >1 year and 27% >2-year survival in heavily pre-treated metastatic breast cancer (MBC) patients treated with Bria-IMT regimen selected for Phase 3TWiST analysis, w","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/01/3304255/0/en/BriaCell-Presents-Positive-Clinical-Data-at-ASCO-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PFS","BK4195","BK4086","BK4231","LU0757428866.USD","LU1815336091.USD","BK4023","ADC","BL","MBC","BK4211","BK4080","CPI","BCTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640958558","title":"Jefferies Sticks to Its Buy Rating for Agree Realty (ADC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2640958558","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640958558?lang=en_us&edition=fundamental","pubTime":"2026-06-01 17:55","pubTimestamp":1780307740,"startTime":"0","endTime":"0","summary":"In a report released today, Joe Dickstein from Jefferies reiterated a Buy rating on Agree Realty, with a price target of $84.00. Dickstein covers t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/jefferies-sticks-to-its-buy-rating-for-agree-realty-adc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/jefferies-sticks-to-its-buy-rating-for-agree-realty-adc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640435931","title":"Agree Realty Corp : Jefferies Assumes Coverage With Buy Rating; Price Target $84 VS $92","url":"https://stock-news.laohu8.com/highlight/detail?id=2640435931","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640435931?lang=en_us&edition=fundamental","pubTime":"2026-06-01 15:58","pubTimestamp":1780300729,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nFWN4261M1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4231","ADC","BK4080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640939036","title":"U.S. RESEARCH ROUNDUP-Palomar Holdings, Replimune Group, Snowflake","url":"https://stock-news.laohu8.com/highlight/detail?id=2640939036","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640939036?lang=en_us&edition=fundamental","pubTime":"2026-06-01 15:39","pubTimestamp":1780299542,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Palomar Holdings, Replimune Group, Snowflake June 1 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, includin","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nL4N4290HL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EGP","COLD","APLE","BXP","CPB","CSR","CZR","DAMD","BKSY","DELL","DRH","CDP","ASTS","BSY","CVS","AMDD","PLCE","ARXS","ADSK","CHRW","PLMR","GOOY","AMDG","GOOW","DEI","AVGO","BKE","CPT","CRDF","CMI","CUZ","DAL","ASTX","ELV","COO","GOOX","GOU","DBI","CNC","AVGU","CTSH","GOOP","ASTN","AEO","CTRE","AMD","GOOGL","FR","DLTR","ADC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154262637","title":"Revised Title","url":"https://stock-news.laohu8.com/highlight/detail?id=1154262637","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154262637?lang=en_us&edition=fundamental","pubTime":"2026-06-01 06:56","pubTimestamp":1780268200,"startTime":"0","endTime":"0","summary":"SBP GROUP (01177) Announces Phase I Clinical Data for TQB6411, an EGFR/c-MET ADC, at 2026 ASCO","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","01177","IE00BZ08YR35.GBP","LU1989771016.USD","IE00BZ08YS42.EUR","BK1515","LU1291159041.SGD","BK4231","LU1496350502.SGD","ADC","BK4585","MET","BK4588","BK1589","LU1989772840.SGD","LU1989772923.USD","BK1521","IE00BZ08YT58.USD","HK0000165453.HKD","BK4162","BK4080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172821871","title":"China Biopharma's Claudin 18.2 ADC LM-302 Demonstrates Encouraging Phase II Data in First-Line Gastric Cancer at ASCO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1172821871","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172821871?lang=en_us&edition=fundamental","pubTime":"2026-06-01 06:50","pubTimestamp":1780267831,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical Limited announced that its wholly-owned subsidiary, Livzon Pharmaceutical Group Science & Technology Development Co., Ltd., presented Phase II clinical data for its...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","BK1191","BK4231","BK1515","HK0000165453.HKD","BK4080","IE00BZ08YT58.USD","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","ADC","BK1521","01177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640867749","title":"Sino Biopharm Showcases Promising Phase I Data for Novel EGFR/c-Met ADC at ASCO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2640867749","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640867749?lang=en_us&edition=fundamental","pubTime":"2026-06-01 06:37","pubTimestamp":1780267054,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical ( ($HK:1177) ) just unveiled an update. Sino Biopharmaceutical’s subsidiary Chia Tai Tianqing has reported Phase I data for ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sino-biopharm-showcases-promising-phase-i-data-for-novel-egfr-c-met-adc-at-asco-2026?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sino-biopharm-showcases-promising-phase-i-data-for-novel-egfr-c-met-adc-at-asco-2026?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADC","BK4080","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639660753","title":"Nobody Can Agree How to Keep the Sharks Out of South Africa's New Club Med -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2639660753","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639660753?lang=en_us&edition=fundamental","pubTime":"2026-05-31 11:00","pubTimestamp":1780196400,"startTime":"0","endTime":"0","summary":"By Alexandra Wexler | Photography by Gulshan Khan for WSJ. BALLITO, South Africa -- Club Med's expansion into South Africa has run into a problem -- and this one's got teeth.\"If you put the shark nets in, all these protected species are going to die -- that's a guarantee,\" said Ryan Daly, a senior scientist at South Africa's Oceanographic Research Institute. \"Are people going to die from a shark attack?There's no sign the standoff over South Africa's first new shark net in two decades will delay the resort's planned opening in July, but the clock is ticking. The installation of the net is waiting on a full environmental-impact assessment.Intense fear surrounding shark attacks along South Africa's Indian Ocean coast harks back decades. The KwaZulu-Natal Sharks Board, whose mandate is to protect swimmers from attacks, say nets have helped significantly reduce fatal encounters since the 1950s, when a spate of attacks devastated local tourism.\"It's silly to go to these lengths and damage t","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4080","ADC","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165452953","title":"ANTENGENE-B Shares Surge Over 5% Following Clinical Approval for Key Phase III Study of ADC Therapy ATG-022 in Gastric Adenocarcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=1165452953","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165452953?lang=en_us&edition=fundamental","pubTime":"2026-05-29 10:12","pubTimestamp":1780020752,"startTime":"0","endTime":"0","summary":"ANTENGENE-B (06996) rose more than 5%. As of the time of writing, the stock was up 5.33% to HK$4.35, with a turnover of HK$3.2719 million. The company announced that it has received approval from the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1583","BK1191","BK4080","BK4134","06996","BK4585","III","VXUS","BK4231","ADC","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639614297","title":"Essential Performance and Real-time Control Without the Baggage","url":"https://stock-news.laohu8.com/highlight/detail?id=2639614297","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639614297?lang=en_us&edition=fundamental","pubTime":"2026-05-29 07:11","pubTimestamp":1780009860,"startTime":"0","endTime":"0","summary":"Microchip’s dsPIC33CK Value Line DSCs offer streamlined design for cost-sensitive applications and consistent pricing regardless of order sizeCHANDLER, Ariz., May  28, 2026  (GLOBE NEWSWIRE) -- Design","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/28/3303347/0/en/Essential-Performance-and-Real-time-Control-Without-the-Baggage.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGXZ23171101.USD","BK4532","LU1064131342.USD","IE00BKVL7J92.USD","LU1543694498.USD","LU2413666426.HKD","LU2237957902.USD","LU1988902786.USD","LU0505663152.USD","LU1620156213.USD","SENT","LU0724618433.USD","LU1064927863.SGD","LU0061474960.USD","LU0234572021.USD","LU2413666004.HKD","LU1104425308.USD","LU1791806182.HKD","LU2413666699.HKD","LU1989772923.USD","LU2413665964.HKD","LIN","LU0096362180.USD","DAC","IE00BD6J9T35.USD","LU0969580561.USD","LU0353189680.USD","DIM","BK4566","LU0506197887.SGD","LU2264538146.SGD","LU0266013472.USD","LU2506952337.HKD","LU0171276677.USD","LU0788108743.HKD","LU1989772840.SGD","IE000M9KFDE8.USD","LU0957791311.USD","LU0963555726.SGD","LU2265009873.SGD","LU1721428933.USD","LU0823399737.USD","LU1596574779.USD","LU2298322129.HKD","LU0300736492.USD","LU1721427968.SGD","LU2506952410.USD","ADC","LU1721428347.USD","LU0300736062.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638666490","title":"Henlius Starts Global Phase 2/3 Trial of ADC HLX43 in Advanced Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2638666490","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638666490?lang=en_us&edition=fundamental","pubTime":"2026-05-28 16:43","pubTimestamp":1779957783,"startTime":"0","endTime":"0","summary":"Shanghai Henlius Biotech, Inc. Class H ( ($HK:2696) ) has provided an update. Shanghai Henlius Biotech has begun dosing the first patient in an int...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/henlius-starts-global-phase-2-3-trial-of-adc-hlx43-in-advanced-lung-cancer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/henlius-starts-global-phase-2-3-trial-of-adc-hlx43-in-advanced-lung-cancer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B66KJ199.SGD","LU0757428866.USD","AEIS","BK4581","ADC","IE00B7SZL793.SGD","BK4157","BK4585","IE0031619046.USD","BK4231","BK4080","IE00B19Z4B17.USD","LU1815336091.USD","XBI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182543112","title":"AbbVie's CD123 ADC Receives FDA Approval for Market Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=1182543112","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182543112?lang=en_us&edition=fundamental","pubTime":"2026-05-28 15:40","pubTimestamp":1779954023,"startTime":"0","endTime":"0","summary":"AbbVie has announced that the U.S. FDA has approved its ADC therapy, Pivekimab sunirine (PVEK), for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN). Information indicates this...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1585245621.USD","LU1093756168.USD","LU0965508806.USD","BK4139","LU0310799852.SGD","LU0310800379.SGD","IE00B2B36J28.USD","LU1989772840.SGD","LU2237443978.SGD","SG9999015945.SGD","BK4231","LU2129689514.USD","LU0289739343.SGD","LU1093756325.SGD","IE000WAW04H5.SGD","LU1496350171.SGD","IE00B4R5TH58.HKD","LU0689626769.HKD","LU2237443622.USD","LU1244550221.USD","LU0234570918.USD","LU0124676726.USD","IE00BN8TJ469.HKD","LU0203347892.USD","LU1839511570.USD","LU0861579265.USD","LU0211328371.USD","IPOS","LU2357627491.SGD","LU1244550577.SGD","SG9999015986.USD","LU0256863902.USD","BK4559","LU0965509283.SGD","LU0058720904.USD","LU1267930573.SGD","LU1496350502.SGD","LU0211327993.USD","LU0553294199.USD","LU0545039389.USD","LU1732799900.SGD","LU2089984988.USD","LU2237443549.SGD","IE00B42XCP33.USD","LU0203345920.USD","LU1551013425.SGD","LU0689472784.USD","IE00BVYPNW00.USD","IE0000B7K699.USD","LU0320765646.SGD","SG9999003800.SGD","LU0868494708.USD","LU1003077747.HKD","LU0985320562.USD","BK4581","LU2347655156.SGD","IE0004445239.USD","LU0795875086.SGD","LU2089284900.SGD","LU2112291526.USD","LU2237443465.HKD","ABBV","BK4588","LU0170899867.USD","BK4550","IE000F7OJYX1.SGD","IE000SO60NU8.SGD","LU0820561818.USD","LU0029864427.USD","LU0795875169.SGD","BK4585","LU0965509010.AUD","LU2237443895.HKD","LU1244550494.USD","IE00BDGV0183.EUR","LU1929549753.HKD","LU2087621335.USD","LU2468319806.SGD","LU0456855351.SGD","LU1162221912.USD","LU1057294990.SGD","LU0256863811.USD","LU1983299246.USD","IE00B19Z3B42.SGD","BK4566","IE00BFTCPJ56.SGD","LU1718418525.SGD","SG9999015978.USD","LU1989772923.USD","IE00B3PB1722.GBP","IE00BVYPNV92.GBP","LU0128525929.USD","SG9999011175.SGD","IE00B19Z3581.USD","LU2089283258.USD","IE00BLSP4452.SGD","LU0708994859.HKD","LU0820561909.HKD","LU0069063385.USD","LU0417517546.SGD","BK4080","IE00BJJMRZ35.SGD","LU0942090050.USD","BK4534","LU0158827948.USD","LU2023251221.USD","IE0009355771.USD","LU2237443382.USD","IE00BJT1NW94.SGD","LU0432979614.USD","LU0965509101.SGD","LU1291159041.SGD","LU0823416689.USD","LU0859254822.USD","IE00BGHQF631.EUR","LU1037948897.HKD","IE00BLSP4239.USD","LU1551013342.USD","IE00BBT3K403.USD","IE000MB6IJN5.SGD","LU0198837287.USD","LU1732800096.USD","BK4533","LU1074936037.SGD","IE000BZT7R73.USD","LU0738911758.USD","LU2133065610.SGD","LU0289739699.SGD","SG9999001440.SGD","LU0882574055.USD","LU0661504455.SGD","LU0943347566.SGD","IE00BSNM7G36.USD","LU1061106388.HKD","IE0002141913.USD","LU0912757837.SGD","LU1023059063.AUD","LU1934455194.USD","LU0289961442.SGD","SG9999015952.SGD","LU0114720955.EUR","LU1037948541.HKD","LU0057025933.USD","ADC","LU1267930490.SGD","LU0098860793.USD","LU1934455863.HKD","LU1430594728.SGD","LU0234572021.USD","LU0472753341.HKD","LU0511384066.AUD","LU2129689431.USD","LU1934455277.USD","LU2129689605.HKD","LU0868494617.USD","LU1989771016.USD","LU0122379950.USD","IE0002270589.USD","LU0949170772.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638468230","title":"“Foundational to Installation Infrastructure”: Comcast Stock (NASDAQ:CMCSA) Gains Discussing Future of Community Connections","url":"https://stock-news.laohu8.com/highlight/detail?id=2638468230","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638468230?lang=en_us&edition=fundamental","pubTime":"2026-05-28 00:02","pubTimestamp":1779897757,"startTime":"0","endTime":"0","summary":"Recently, entertainment giant Comcast ($CMCSA) sat down with the Association of Defense Communities (ADC) to discuss the future of community connec...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/foundational-to-installation-infrastructure-comcast-stock-nasdaqcmcsa-gains-discussing-future-of-community-connections?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/foundational-to-installation-infrastructure-comcast-stock-nasdaqcmcsa-gains-discussing-future-of-community-connections?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0942090050.USD","QQQJ","QQQ","TQQQ","QLD","LU0068578508.USD","ADC","BK4100","BK4115","BK4507","BK4581","BK4598","LU0029864427.USD","IYW","LU1894683348.USD","BK4534","IE00B19Z9P08.USD","BK4550","QID","IE00B894F039.SGD","LU1244550577.SGD","NQmain","QDTE","QYLG","QQQA","QQQY","TECS","ONEQ","LU0878866978.SGD","LU1894683264.USD","LU1267930573.SGD","LU0708994859.HKD","PSQ","JEPQ","IE00BSNM7G36.USD","LU0433182093.SGD","QQQE","TQQY","CMCSA","QQQM","LU0320765489.SGD","NVIW.SI",".IXIC","FTEC","MNQmain","NDX","LU0980610538.SGD","SQQQ","LU0868494708.USD","GPIQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638686399","title":"Asahi Kaisei acquires license rights for ADC tech from Noguchi Institute","url":"https://stock-news.laohu8.com/highlight/detail?id=2638686399","media":"TIPRANKS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638686399?lang=en_us&edition=fundamental","pubTime":"2026-05-27 21:46","pubTimestamp":1779889607,"startTime":"0","endTime":"0","summary":"Asahi Kasei Life Science has acquired the license rights for a novel antibody-drug conjugate technology from The Noguchi Institute. This modality e...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/asahi-kaisei-acquires-license-rights-for-adc-tech-from-noguchi-institute-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/asahi-kaisei-acquires-license-rights-for-adc-tech-from-noguchi-institute-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4231","ADC","BK4080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132933124","title":"DUALITYBIO-B Surges Over 5% on Global Phase III Trial Milestone for B7-H3 ADC with BioNTech","url":"https://stock-news.laohu8.com/highlight/detail?id=1132933124","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132933124?lang=en_us&edition=fundamental","pubTime":"2026-05-27 15:06","pubTimestamp":1779865584,"startTime":"0","endTime":"0","summary":"DUALITYBIO-B (09606) rose more than 5%. At the time of writing, the stock was up 3.14% to HK$222.6, with a turnover of HK$152 million. The catalyst for the move is recent news from the company's...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4231","BK1161","LU2543165471.USD","BK4080","BK4585","HK0000500386.USD","BK4588","HK0000252160.HKD","ADC","09606","VXUS","HK0000252152.HKD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.agreerealty.com","stockEarnings":[{"period":"1week","weight":-0.0396},{"period":"1month","weight":-0.0509},{"period":"3month","weight":-0.1154},{"period":"6month","weight":-0.0269},{"period":"1year","weight":-0.0376},{"period":"ytd","weight":0.0061}],"compareEarnings":[{"period":"1week","weight":0.0173},{"period":"1month","weight":0.0526},{"period":"3month","weight":0.115},{"period":"6month","weight":0.1092},{"period":"1year","weight":0.287},{"period":"ytd","weight":0.1124}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Agree Realty Corporation (the Company), a Maryland corporation, is a fully integrated real estate investment trust (REIT) primarily focused on the ownership, acquisition, development and management of retail properties net leased to industry leading tenants. The Company was founded in 1971 by its current Executive Chairman, Richard Agree, and its common stock was listed on the New York Stock Exchange in 1994. As of March 31, 2024, the Company owned 2,161 properties, with a total gross leasable area (GLA) of approximately 44.9 million square feet.","yearOnYearQuotes":[{"month":1,"riseRate":0.59375,"avgChangeRate":-0.003579},{"month":2,"riseRate":0.46875,"avgChangeRate":0.002186},{"month":3,"riseRate":0.5625,"avgChangeRate":0.012831},{"month":4,"riseRate":0.59375,"avgChangeRate":0.003425},{"month":5,"riseRate":0.484848,"avgChangeRate":0.013996},{"month":6,"riseRate":0.636364,"avgChangeRate":0.00913},{"month":7,"riseRate":0.65625,"avgChangeRate":0.022845},{"month":8,"riseRate":0.46875,"avgChangeRate":0.002201},{"month":9,"riseRate":0.46875,"avgChangeRate":-0.006321},{"month":10,"riseRate":0.5625,"avgChangeRate":-0.000339},{"month":11,"riseRate":0.65625,"avgChangeRate":0.003584},{"month":12,"riseRate":0.46875,"avgChangeRate":0.00994}],"exchange":"NYSE","name":"Agree","nameEN":"Agree"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Agree(ADC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Agree(ADC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Agree,ADC,Agree股票,Agree股票老虎,Agree股票老虎国际,Agree行情,Agree股票行情,Agree股价,Agree股市,Agree股票价格,Agree股票交易,Agree股票购买,Agree股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Agree(ADC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Agree(ADC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}